Biodelivery Sciences International Inc 's ROA from the fourth quarter of 2021 to the fourth quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Biodelivery Sciences International Inc 's ROA in the fourth quarter of 2021?
Biodelivery Sciences International Inc achieved a return on average assets (ROA) of 39.87 % in its fourth quarter of 2021, this is above BDSI's average return on assets of -33.96%.
Biodelivery Sciences International Inc assets over the 12 months ending in its fourth quarter of 2021 are valued at $213 million

ROA has improved compared to 15.05% in the third quarter of 2021, due to net income growth.

However, within the Healthcare sector 43 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Dec 31 2021 quarter, so far to 204, from total ROA ranking in the third quarter of 2021 at 594.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter
Y / Y Total Assets Change	9.69 %	11.89 %	22.5 %	-2.42 %	23.76 %
Y / Y Net Income Change	526.56 %	-28.92 %	678.03 %	5.46 %	-
Net Income (TTM) in million	85	31	34	26	26
Return On Assets (TTM)	39.87 %	15.05 %	16.78 %	13.49 %	13.27 %
BDSI's Total Ranking	# 204	# 594	# 484	# 567	# 502
Total Assets (TTM) in million	264	194	202	192	240
Seq. Total Assets Change	35.99 %	-3.87 %	5.17 %	-20.22 %	38.71 %
Seq. Net Income Change	858.01 %	-26.42 %	73.08 %	-48.64 %	8.68 %

BDSI's 5 Years Annual ROA >> Back to BDSI Management Effectiveness >> Compare BDSI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 24
Sector	# 44
Overall	# 198

Return On Assets Statistics
High	Average	Low
31.63 %	-33.96 %	-115.01 %
(Dec 31 2021)		(Dec 31 2013)

Financial Statements
Biodelivery Sciences International Inc 's Assets	$ 264 million	BDSI's Balance sheet
Biodelivery Sciences International Inc 's Income	$ 64 million	Quarterly BDSI's Income Statement
BDSI's Income by Division		See BDSI's Income by Division

Annual Return On Assets	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017
Y / Y Total Assets Change	40.98 %	2.29 %	68.52 %	23.19 %	68.38 %
Total Assets in million	264	187	183	109	88
Y / Y Net Income Change	230.05 %	-	-	-	-
Net Income in million	85	26	-15	-34	5
Annual Return On Assets	32.17 %	13.74 %	-8.37 %	-31.2 %	6 %

BDSI's 5 Years Annual ROA >> Back to BDSI Management Effectiveness >> Compare BDSI ROA to its Competitors

Comment on BDSI's ROA in the fiscal year ending 2021

In the fiscal year 2021 ROA improved to 32.17 % compared to prior year, due to annual net income growth of 230.05 % to $84.86 million, while value of Biodelivery Sciences International Inc 's overall assets grew just by 40.98 % to $263.78 million, compared to $263.78 a year before.

More Return On Assets Ratios
BDSI's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BDSI's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BDSI's Competitors
Subscribers only: Roa for Biodelivery Sciences International Inc 's Suppliers
Subscribers only: Return On Assets for BDSI's Customers

You may also want to know
BDSI's Roi	BDSI's Inventory Turnover Ratio	BDSI's Growth Rates	BDSI's Dividend Comparisons
	BDSI's Profitability Ratios	BDSI's Asset Turnover Ratio	BDSI's Dividend Growth
BDSI's Roe	BDSI's Valuation Ratios	BDSI's Financial Strength Ratios	BDSI's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2021, within Healthcare Sector	ROA
Altamira Therapeutics Ltd	99.05 %
Omeros Corporation	91.45 %
Galmed Pharmaceuticals Ltd	88.51 %
Agios Pharmaceuticals Inc	87.42 %
Sinovac Biotech Ltd	84.25 %
Vyne Therapeutics Inc	67.97 %
Nascent Biotech Inc	67.76 %
Moderna Inc	65.57 %
Biontech Se	65.02 %
Vivos Therapeutics Inc	56.85 %
Ovid Therapeutics Inc	55.93 %
Ironwood Pharmaceuticals inc	55.44 %
Glucotrack Inc	50.63 %
Biomx Inc	50.23 %
Notable Labs Ltd	49.82 %
Uniqure N v	48.26 %
Silo Pharma Inc	48.22 %
Reflect Scientific Inc	45.37 %
Fulgent Genetics Inc	44.68 %
Siga Technologies Inc	44.61 %
Carisma Therapeutics Inc	40.94 %
Innoviva Inc	39.97 %
Vir Biotechnology Inc	39.46 %
Halozyme Therapeutics Inc	37.62 %
Molecular Templates Inc	36.62 %
Semler Scientific inc	36.59 %
Regeneron Pharmaceuticals Inc	36.55 %
Iteos Therapeutics Inc	34.90 %
Inmode Ltd	34.50 %
Co diagnostics Inc	33.38 %

Date modified: 2026-09-08T15:10:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.